Matching scans and biopsy results in colon and rectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy-confirmed adenocarcinoma in the colon, sigmoid, or rectum (or you’ll be removed if later pathology shows a different type).
- Your cancer may be treated with surgery (it can be removed).
- Your doctors have done cancer staging scans to look for spread, before treatment.
- If you receive treatment before surgery (neoadjuvant therapy), you also had a scan after that treatment.
- You are 16 years old or older and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how rectal cancer responds to the usual chemotherapy and radiation given before surgery. It aims to learn if certain molecular features of your tumor can predict how well it responds to treatment.
This study looks back at medical records to compare how MRI scans and lab tests describe tumour deposits (small clusters of cancer cells) in people with rectal cancer. It aims to improve how doctors report these deposits in the future, which may help guide treatment decisions.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
This study uses MRI scans to better plan “curative” treatment (aimed at cure) for sigmoid colon cancer before surgery. It is for people who may still be deciding on the radical (major, curative) treatment plan and who can safely have an MRI.
This trial reviews MRI scans and pathology reports from people with rectal cancer to improve how the disease is diagnosed and treated. It may help doctors better plan care for future patients.
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
Hear when a new Adenocarcinoma of the Rectum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.